Biochemical and histopathological evaluation of systemic and ocular toxicity of favipiravir in rats-Reference-Cited by-同舟云学术

Biochemical and histopathological evaluation of systemic and ocular toxicity of favipiravir in rats

Published:2024-01-04 Issue: Volume: Page:1-8
ISSN:1556-9527
Container-title:Cutaneous and Ocular Toxicology
language:en
Short-container-title:Cutaneous and Ocular Toxicology

Author:

Özcan Delil¹,Özçelik Fatih²,Mammadov Renad³,Aktaş Mehmet⁴,Altındağ Fikret⁵,Alkan Abdurrahman Alpaslan⁶,Karapapak Murat⁷,Altuner Durdu³,Süleyman Halis³

Affiliation:

1. Department of Ophthalmology, University of Health Sciences, Seyrantepe Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey

2. Department of Medical Biochemistry, University of Health Sciences, Seyrantepe Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey

3. Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey

4. Department of Biochemistry, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey

5. Department of Histology and Embryology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkey

6. Department of Ophthalmology, İstanbul Cerrahi Hospital, İstanbul, Turkey

7. Department of Ophthalmology, Başakşehir Çam and Sakura City Hospital, İstanbul, Turkey

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15569527.2023.2300788

Reference35 articles.

1. Favipiravir in Therapy of Viral Infections

2. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

3. Favipiravir (T-705), a novel viral RNA polymerase inhibitor

4. Mechanism of Action of T-705 against Influenza Virus

5. 200 Mg. Report on the deliberation results;Tablet A.;Evaluation and licensing division, pharmaceutical and food safety bureau,2014